|
Upon receipt, the icd was subjected to an electrical analysis.Confirming the clinical observation, the device could not be interrogated.Therefore the icd was opened to inspect the inner assembly.The visual inspection of the inner assembly showed no anomalies.The measurement of the battery voltage revealed a depleted battery.The electronic module was attached to an external power supply to test the functionality of the electronic module.Thereby, the electrical parameters, particularly the current consumption of the electronic module, were found to be normal and as expected.The ability of the electronic module to deliver therapies was verified.The anti-bradycardia pacing pulses proved to be normal and in amplitude and frequency as programmed.A fibrillation signal was applied, and the device delivered a defibrillation shock as specified, documenting a normal and expected sensing and shock delivery.In particular, the specified energy level was reached.Therefore, the battery was sent to the manufacturer for further analysis.The manufacturing records of the battery were inspected, documenting that the battery parameters were within specification during the battery manufacturing.No anomalies were documented during the production process, associated with this battery.The visual inspection of the battery did not reveal any external signs of damage.The voltage measurement confirmed a depleted battery.In a next step, the battery was opened to inspect the individual components of the battery.These were as expected in accordance with the battery state of charge.There was no indication of a battery failure.In conclusion, the clinical observation could be confirmed.However, despite a thorough analysis of the icd no conclusion can be drawn regarding the root cause.There was no indication of a material or manufacturing problem.
|